Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer
NCT05785845 is an interventional trial sponsored by Washington University School of Medicine. As of 21 Nov 2026, it is completed. It studies Early Stage Non-small Cell Lung Cancer and Non-small Cell Lung Cancer. The registry lists an enrollment of 17 participants at 1 site in 1 country. The registry lists a start date of 10 Apr 2023 and a primary completion date of 2 Jun 2026. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT05785845 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Washington University School of Medicine |
| Enrollment | 17 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Early Stage Non-small Cell Lung Cancer and Non-small Cell Lung Cancer |
| Start | 10 Apr 2023 |
| Primary completion | 2 Jun 2026 |
| Study completion | 2 Jun 2026 |
| Last update posted | 6 Aug 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Pamela Samson, M.D., MPHS
Washington University School of Medicine
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Washington University School of Medicine
St Louis
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT05785845
Each answer restates registry values shown on this page.
What is NCT05785845?
NCT05785845 is an interventional trial sponsored by Washington University School of Medicine. It studies Early Stage Non-small Cell Lung Cancer and Non-small Cell Lung Cancer.
Who leads NCT05785845?
The registry names Pamela Samson, M.D., MPHS (principal investigator, Washington University School of Medicine) as the overall official.
Where does NCT05785845 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT05785845 end?
The registry lists a primary completion date of 2 Jun 2026 and a study completion date of 2 Jun 2026. The sponsor last updated the record on 6 Aug 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.